
As the healthcare landscape evolves, pharmaceutical companies are being driven to embrace new, unique partnerships to go beyond the pill, writes Weng Si Ho.
Weng Si Ho is Director of Biomedical Sciences, Singapore Economic Development Board

Published: January 31st 2017 | Updated: